1. Home
  2. MNSO vs RARE Comparison

MNSO vs RARE Comparison

Compare MNSO & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNSO
  • RARE
  • Stock Information
  • Founded
  • MNSO 2013
  • RARE 2010
  • Country
  • MNSO China
  • RARE United States
  • Employees
  • MNSO N/A
  • RARE N/A
  • Industry
  • MNSO Department/Specialty Retail Stores
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNSO Consumer Discretionary
  • RARE Health Care
  • Exchange
  • MNSO Nasdaq
  • RARE Nasdaq
  • Market Cap
  • MNSO 5.5B
  • RARE 5.2B
  • IPO Year
  • MNSO 2020
  • RARE 2014
  • Fundamental
  • Price
  • MNSO $17.00
  • RARE $46.02
  • Analyst Decision
  • MNSO Hold
  • RARE Strong Buy
  • Analyst Count
  • MNSO 4
  • RARE 14
  • Target Price
  • MNSO $20.90
  • RARE $86.79
  • AVG Volume (30 Days)
  • MNSO 1.7M
  • RARE 974.4K
  • Earning Date
  • MNSO 11-29-2024
  • RARE 11-05-2024
  • Dividend Yield
  • MNSO 3.33%
  • RARE N/A
  • EPS Growth
  • MNSO 110.51
  • RARE N/A
  • EPS
  • MNSO 1.02
  • RARE N/A
  • Revenue
  • MNSO $1,951,627,722.00
  • RARE $522,745,000.00
  • Revenue This Year
  • MNSO $52.47
  • RARE $27.29
  • Revenue Next Year
  • MNSO $21.63
  • RARE $18.30
  • P/E Ratio
  • MNSO $17.44
  • RARE N/A
  • Revenue Growth
  • MNSO 39.43
  • RARE 27.44
  • 52 Week Low
  • MNSO $12.51
  • RARE $37.02
  • 52 Week High
  • MNSO $26.54
  • RARE $60.37
  • Technical
  • Relative Strength Index (RSI)
  • MNSO 43.56
  • RARE 34.61
  • Support Level
  • MNSO $17.34
  • RARE $43.04
  • Resistance Level
  • MNSO $17.94
  • RARE $53.04
  • Average True Range (ATR)
  • MNSO 0.65
  • RARE 2.14
  • MACD
  • MNSO -0.24
  • RARE -0.35
  • Stochastic Oscillator
  • MNSO 9.01
  • RARE 28.57

About MNSO MINISO Group Holding Limited

MINISO Group Holding Ltd is a retailer offering a variety of design-led lifestyle products. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: